 Tellen Bennett
Concepts (292)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 15 | 2023 | 348 | 5.020 |
Why?
| | Intracranial Pressure | 7 | 2022 | 55 | 2.630 |
Why?
| | Intensive Care Units, Pediatric | 12 | 2022 | 208 | 2.400 |
Why?
| | Brain Injuries | 8 | 2018 | 507 | 2.360 |
Why?
| | Sepsis | 9 | 2024 | 563 | 2.330 |
Why?
| | Intracranial Hypertension | 4 | 2022 | 40 | 1.920 |
Why?
| | Decision Support Systems, Clinical | 4 | 2023 | 188 | 1.750 |
Why?
| | Critical Care | 6 | 2023 | 563 | 1.690 |
Why?
| | Hospital Mortality | 15 | 2024 | 897 | 1.650 |
Why?
| | Child | 60 | 2024 | 20014 | 1.620 |
Why?
| | Machine Learning | 5 | 2023 | 353 | 1.520 |
Why?
| | Aftercare | 4 | 2024 | 208 | 1.460 |
Why?
| | Seizures | 3 | 2018 | 381 | 1.400 |
Why?
| | Databases, Factual | 14 | 2023 | 1298 | 1.330 |
Why?
| | Shock, Septic | 4 | 2024 | 217 | 1.090 |
Why?
| | Child, Preschool | 28 | 2024 | 9938 | 1.010 |
Why?
| | Critical Illness | 8 | 2022 | 719 | 1.010 |
Why?
| | Infant | 28 | 2022 | 8625 | 0.990 |
Why?
| | Monitoring, Physiologic | 3 | 2019 | 290 | 0.990 |
Why?
| | Humans | 95 | 2024 | 125131 | 0.970 |
Why?
| | Recovery of Function | 3 | 2019 | 620 | 0.920 |
Why?
| | Respiration, Artificial | 5 | 2022 | 595 | 0.900 |
Why?
| | Outpatients | 6 | 2023 | 347 | 0.880 |
Why?
| | Pediatrics | 4 | 2023 | 1046 | 0.880 |
Why?
| | Retrospective Studies | 30 | 2024 | 13708 | 0.840 |
Why?
| | Multiple Organ Failure | 6 | 2024 | 167 | 0.830 |
Why?
| | Connective Tissue Diseases | 1 | 2023 | 58 | 0.820 |
Why?
| | Severity of Illness Index | 5 | 2022 | 2848 | 0.710 |
Why?
| | Bacterial Infections | 1 | 2022 | 238 | 0.700 |
Why?
| | Trauma Severity Indices | 3 | 2017 | 131 | 0.690 |
Why?
| | Forecasting | 2 | 2021 | 379 | 0.690 |
Why?
| | Adolescent | 27 | 2023 | 19411 | 0.680 |
Why?
| | Wounds and Injuries | 5 | 2019 | 833 | 0.670 |
Why?
| | Infant, Newborn | 15 | 2017 | 5456 | 0.650 |
Why?
| | Disability Evaluation | 2 | 2018 | 290 | 0.650 |
Why?
| | Male | 41 | 2024 | 60792 | 0.620 |
Why?
| | Female | 42 | 2024 | 64889 | 0.620 |
Why?
| | Pandemics | 5 | 2023 | 1434 | 0.620 |
Why?
| | Hospitalization | 6 | 2022 | 1960 | 0.620 |
Why?
| | Specialties, Surgical | 1 | 2019 | 77 | 0.610 |
Why?
| | Tranexamic Acid | 1 | 2018 | 43 | 0.610 |
Why?
| | Electronic Health Records | 7 | 2023 | 875 | 0.610 |
Why?
| | Patient Discharge | 8 | 2024 | 857 | 0.600 |
Why?
| | Hypothermia, Induced | 1 | 2018 | 73 | 0.590 |
Why?
| | Neurophysiological Monitoring | 1 | 2017 | 10 | 0.570 |
Why?
| | Child Health | 1 | 2019 | 142 | 0.570 |
Why?
| | Nurses | 1 | 2019 | 159 | 0.560 |
Why?
| | Neurosurgical Procedures | 2 | 2023 | 168 | 0.560 |
Why?
| | Algorithms | 4 | 2023 | 1618 | 0.550 |
Why?
| | Organ Dysfunction Scores | 5 | 2024 | 47 | 0.550 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 292 | 0.550 |
Why?
| | Computer Security | 2 | 2021 | 23 | 0.550 |
Why?
| | Chronic Disease | 2 | 2022 | 1684 | 0.530 |
Why?
| | Health Services Research | 1 | 2019 | 384 | 0.520 |
Why?
| | Health Status Indicators | 1 | 2016 | 169 | 0.520 |
Why?
| | Patient Readmission | 2 | 2018 | 694 | 0.490 |
Why?
| | Anticonvulsants | 1 | 2017 | 192 | 0.490 |
Why?
| | Physicians | 1 | 2023 | 836 | 0.490 |
Why?
| | Electroencephalography | 1 | 2017 | 400 | 0.490 |
Why?
| | Medical Record Linkage | 2 | 2015 | 60 | 0.480 |
Why?
| | Medical Records Systems, Computerized | 1 | 2015 | 94 | 0.480 |
Why?
| | Child, Hospitalized | 1 | 2015 | 49 | 0.470 |
Why?
| | Glasgow Coma Scale | 5 | 2023 | 175 | 0.470 |
Why?
| | Cohort Studies | 11 | 2023 | 5348 | 0.470 |
Why?
| | Spinal Injuries | 1 | 2015 | 54 | 0.470 |
Why?
| | United States | 16 | 2022 | 13613 | 0.450 |
Why?
| | Cervical Vertebrae | 1 | 2015 | 121 | 0.450 |
Why?
| | Models, Biological | 1 | 2021 | 1753 | 0.450 |
Why?
| | Mannitol | 2 | 2022 | 34 | 0.450 |
Why?
| | Software | 1 | 2018 | 647 | 0.440 |
Why?
| | Hypertension | 1 | 2022 | 1257 | 0.440 |
Why?
| | Supervised Machine Learning | 3 | 2023 | 13 | 0.440 |
Why?
| | Saline Solution, Hypertonic | 2 | 2022 | 56 | 0.440 |
Why?
| | Decision Support Techniques | 1 | 2017 | 395 | 0.430 |
Why?
| | Macrophage Activation Syndrome | 1 | 2012 | 12 | 0.430 |
Why?
| | Speech Therapy | 1 | 2013 | 21 | 0.420 |
Why?
| | Emergency Service, Hospital | 3 | 2021 | 1970 | 0.420 |
Why?
| | Arthritis, Juvenile | 1 | 2012 | 42 | 0.410 |
Why?
| | Physical Therapy Specialty | 1 | 2013 | 37 | 0.410 |
Why?
| | Injury Severity Score | 5 | 2018 | 554 | 0.390 |
Why?
| | Occupational Therapy | 1 | 2013 | 77 | 0.390 |
Why?
| | Risk Factors | 10 | 2023 | 9549 | 0.390 |
Why?
| | Ferritins | 1 | 2011 | 61 | 0.390 |
Why?
| | Brain | 2 | 2014 | 2639 | 0.370 |
Why?
| | Fluid Therapy | 1 | 2012 | 155 | 0.360 |
Why?
| | Inpatients | 2 | 2022 | 414 | 0.360 |
Why?
| | Hospitals, Pediatric | 4 | 2018 | 517 | 0.350 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2010 | 50 | 0.350 |
Why?
| | Models, Statistical | 1 | 2014 | 664 | 0.350 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2012 | 236 | 0.350 |
Why?
| | Phenotype | 5 | 2023 | 3153 | 0.340 |
Why?
| | Length of Stay | 4 | 2023 | 1077 | 0.330 |
Why?
| | Ki-67 Antigen | 2 | 2020 | 115 | 0.330 |
Why?
| | Prospective Studies | 6 | 2024 | 6818 | 0.330 |
Why?
| | Prognosis | 5 | 2022 | 3616 | 0.320 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2010 | 188 | 0.310 |
Why?
| | Tomography, X-Ray Computed | 2 | 2015 | 2539 | 0.310 |
Why?
| | Proteome | 2 | 2022 | 359 | 0.300 |
Why?
| | Systemic Inflammatory Response Syndrome | 3 | 2024 | 83 | 0.300 |
Why?
| | Survival Rate | 4 | 2019 | 1799 | 0.280 |
Why?
| | Infant Equipment | 1 | 2006 | 7 | 0.280 |
Why?
| | Protective Devices | 1 | 2006 | 27 | 0.270 |
Why?
| | Comorbidity | 2 | 2022 | 1635 | 0.270 |
Why?
| | Qualitative Research | 2 | 2023 | 1021 | 0.270 |
Why?
| | Transcriptome | 2 | 2022 | 801 | 0.260 |
Why?
| | Accidents, Traffic | 2 | 2006 | 186 | 0.250 |
Why?
| | Adult | 18 | 2023 | 33167 | 0.250 |
Why?
| | Disease Progression | 5 | 2023 | 2577 | 0.250 |
Why?
| | Pneumonia, Ventilator-Associated | 2 | 2016 | 43 | 0.250 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2021 | 259 | 0.250 |
Why?
| | Logistic Models | 4 | 2018 | 2040 | 0.220 |
Why?
| | Noninvasive Ventilation | 1 | 2024 | 36 | 0.220 |
Why?
| | Microscopy | 2 | 2021 | 136 | 0.210 |
Why?
| | Lower Extremity | 1 | 2006 | 356 | 0.210 |
Why?
| | Vital Signs | 1 | 2022 | 45 | 0.200 |
Why?
| | Blood Pressure Determination | 1 | 2022 | 139 | 0.200 |
Why?
| | Blood | 1 | 2022 | 101 | 0.190 |
Why?
| | Focus Groups | 1 | 2023 | 408 | 0.190 |
Why?
| | Creatine | 1 | 2001 | 56 | 0.190 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 52 | 0.190 |
Why?
| | Myocarditis | 1 | 2022 | 99 | 0.190 |
Why?
| | Survivors | 2 | 2022 | 460 | 0.190 |
Why?
| | Alanine | 1 | 2021 | 104 | 0.190 |
Why?
| | Middle Aged | 8 | 2023 | 29112 | 0.190 |
Why?
| | Fractures, Bone | 1 | 2006 | 390 | 0.190 |
Why?
| | Hydroxychloroquine | 1 | 2021 | 58 | 0.190 |
Why?
| | Interferons | 1 | 2022 | 157 | 0.190 |
Why?
| | Common Data Elements | 1 | 2020 | 10 | 0.190 |
Why?
| | Morbidity | 1 | 2022 | 310 | 0.190 |
Why?
| | Age Distribution | 1 | 2022 | 384 | 0.180 |
Why?
| | Washington | 2 | 2011 | 138 | 0.180 |
Why?
| | Body Temperature | 1 | 2001 | 236 | 0.180 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 1 | 2021 | 75 | 0.180 |
Why?
| | Early Diagnosis | 1 | 2022 | 237 | 0.180 |
Why?
| | Intersectoral Collaboration | 1 | 2021 | 62 | 0.180 |
Why?
| | Social Determinants of Health | 1 | 2023 | 147 | 0.180 |
Why?
| | Physical Exertion | 1 | 2001 | 236 | 0.180 |
Why?
| | Acute Lung Injury | 1 | 2023 | 319 | 0.170 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2021 | 562 | 0.170 |
Why?
| | Aged | 8 | 2024 | 20859 | 0.170 |
Why?
| | Databases, Genetic | 1 | 2021 | 266 | 0.170 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2023 | 256 | 0.170 |
Why?
| | Neurosurgeons | 1 | 2019 | 18 | 0.170 |
Why?
| | Acute Disease | 1 | 2022 | 1016 | 0.170 |
Why?
| | Dexamethasone | 1 | 2021 | 329 | 0.160 |
Why?
| | Antiviral Agents | 2 | 2023 | 673 | 0.160 |
Why?
| | Registries | 2 | 2018 | 2050 | 0.160 |
Why?
| | Young Adult | 6 | 2023 | 11384 | 0.160 |
Why?
| | Critical Care Nursing | 1 | 2019 | 31 | 0.160 |
Why?
| | Medicine | 1 | 2020 | 112 | 0.160 |
Why?
| | Intensive Care Units | 2 | 2023 | 663 | 0.160 |
Why?
| | Cerebrovascular Circulation | 1 | 2021 | 239 | 0.160 |
Why?
| | Programming Languages | 1 | 2018 | 25 | 0.160 |
Why?
| | Information Dissemination | 1 | 2021 | 229 | 0.160 |
Why?
| | Metabolome | 1 | 2021 | 307 | 0.150 |
Why?
| | ROC Curve | 2 | 2023 | 501 | 0.150 |
Why?
| | Maternal-Child Health Centers | 1 | 1997 | 9 | 0.150 |
Why?
| | Immunohistochemistry | 2 | 2020 | 1743 | 0.150 |
Why?
| | National Health Programs | 1 | 1997 | 23 | 0.150 |
Why?
| | Risk Assessment | 3 | 2017 | 3274 | 0.150 |
Why?
| | User-Computer Interface | 1 | 2019 | 171 | 0.150 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2019 | 249 | 0.140 |
Why?
| | Hyperlipoproteinemia Type I | 1 | 2016 | 7 | 0.140 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 2016 | 16 | 0.140 |
Why?
| | Interviews as Topic | 1 | 2019 | 649 | 0.140 |
Why?
| | Cause of Death | 2 | 2018 | 394 | 0.140 |
Why?
| | Multivariate Analysis | 3 | 2017 | 1561 | 0.140 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 231 | 0.140 |
Why?
| | Pneumonia | 1 | 2022 | 610 | 0.140 |
Why?
| | Heart Failure | 2 | 2023 | 2154 | 0.130 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 344 | 0.130 |
Why?
| | Propensity Score | 1 | 2017 | 257 | 0.130 |
Why?
| | Follow-Up Studies | 3 | 2017 | 4824 | 0.130 |
Why?
| | Cell Nucleus | 1 | 2019 | 593 | 0.130 |
Why?
| | Trauma Centers | 2 | 2016 | 411 | 0.130 |
Why?
| | Retinal Diseases | 1 | 2016 | 81 | 0.130 |
Why?
| | Blood Pressure | 1 | 2022 | 1735 | 0.130 |
Why?
| | Medical Staff, Hospital | 1 | 2016 | 84 | 0.130 |
Why?
| | Hyperlipidemias | 1 | 2016 | 144 | 0.130 |
Why?
| | Women's Health | 1 | 1997 | 282 | 0.130 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1885 | 0.130 |
Why?
| | Comparative Effectiveness Research | 1 | 2016 | 145 | 0.120 |
Why?
| | Organizational Culture | 1 | 2016 | 131 | 0.120 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3047 | 0.120 |
Why?
| | Regression Analysis | 1 | 2017 | 1047 | 0.120 |
Why?
| | Mass Screening | 1 | 2021 | 1119 | 0.110 |
Why?
| | Hospitals, High-Volume | 1 | 2014 | 49 | 0.110 |
Why?
| | Military Personnel | 1 | 2001 | 612 | 0.110 |
Why?
| | Area Under Curve | 1 | 2014 | 305 | 0.110 |
Why?
| | Treatment Outcome | 4 | 2022 | 9790 | 0.110 |
Why?
| | Patient Safety | 1 | 2016 | 306 | 0.110 |
Why?
| | Proportional Hazards Models | 2 | 2017 | 1191 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2021 | 1280 | 0.100 |
Why?
| | Deglutition | 1 | 2013 | 69 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1559 | 0.100 |
Why?
| | Quality of Life | 1 | 2024 | 2580 | 0.100 |
Why?
| | Mycophenolic Acid | 1 | 2012 | 81 | 0.100 |
Why?
| | Cyclophosphamide | 1 | 2012 | 229 | 0.100 |
Why?
| | Cyclosporine | 1 | 2012 | 174 | 0.100 |
Why?
| | Antibodies, Monoclonal | 3 | 2022 | 1300 | 0.100 |
Why?
| | Time Factors | 4 | 2019 | 6780 | 0.100 |
Why?
| | Gastrostomy | 1 | 2012 | 93 | 0.100 |
Why?
| | Medical Audit | 1 | 2011 | 82 | 0.100 |
Why?
| | Datasets as Topic | 2 | 2022 | 106 | 0.090 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2014 | 235 | 0.090 |
Why?
| | Quality of Health Care | 1 | 2016 | 658 | 0.090 |
Why?
| | Tracheostomy | 1 | 2012 | 104 | 0.090 |
Why?
| | Case-Control Studies | 3 | 2023 | 3326 | 0.090 |
Why?
| | Aged, 80 and over | 2 | 2021 | 6936 | 0.090 |
Why?
| | Consensus | 2 | 2024 | 577 | 0.090 |
Why?
| | Antibodies, Viral | 2 | 2023 | 561 | 0.080 |
Why?
| | Patient Transfer | 1 | 2011 | 160 | 0.080 |
Why?
| | Age Factors | 3 | 2014 | 3152 | 0.080 |
Why?
| | Data Collection | 2 | 2022 | 682 | 0.080 |
Why?
| | Interleukin-1 | 1 | 2012 | 984 | 0.080 |
Why?
| | Gestational Age | 1 | 2010 | 797 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2236 | 0.070 |
Why?
| | Guideline Adherence | 1 | 2011 | 563 | 0.070 |
Why?
| | Incidence | 1 | 2010 | 2578 | 0.060 |
Why?
| | Respiration | 1 | 2024 | 201 | 0.050 |
Why?
| | Health Facilities | 1 | 2023 | 78 | 0.050 |
Why?
| | Immunization, Passive | 1 | 2022 | 83 | 0.050 |
Why?
| | Ritonavir | 1 | 2023 | 74 | 0.050 |
Why?
| | Health Insurance Portability and Accountability Act | 1 | 2022 | 18 | 0.050 |
Why?
| | International Classification of Diseases | 1 | 2023 | 131 | 0.050 |
Why?
| | Biochemical Phenomena | 1 | 2001 | 10 | 0.050 |
Why?
| | Data Accuracy | 1 | 2022 | 66 | 0.050 |
Why?
| | Treatment Failure | 1 | 2022 | 348 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 364 | 0.050 |
Why?
| | Access to Information | 1 | 2021 | 56 | 0.050 |
Why?
| | Government Regulation | 1 | 2021 | 50 | 0.050 |
Why?
| | Ethics Committees, Research | 1 | 2021 | 48 | 0.050 |
Why?
| | Health Resources | 1 | 2022 | 137 | 0.050 |
Why?
| | Los Angeles | 1 | 2020 | 62 | 0.050 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2021 | 123 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 119 | 0.040 |
Why?
| | Delphi Technique | 1 | 2020 | 179 | 0.040 |
Why?
| | Abbreviated Injury Scale | 1 | 2019 | 22 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2023 | 1183 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2001 | 1366 | 0.040 |
Why?
| | Neuroendocrine Tumors | 1 | 2019 | 89 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2021 | 471 | 0.040 |
Why?
| | Patient Admission | 1 | 2019 | 198 | 0.040 |
Why?
| | North Carolina | 1 | 1997 | 136 | 0.040 |
Why?
| | Body Composition | 1 | 2001 | 679 | 0.040 |
Why?
| | Biomedical Research | 1 | 2023 | 641 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2022 | 745 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2001 | 1725 | 0.040 |
Why?
| | Policy Making | 1 | 1997 | 90 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2021 | 743 | 0.040 |
Why?
| | Fundus Oculi | 1 | 2016 | 42 | 0.030 |
Why?
| | Metabolomics | 1 | 2021 | 551 | 0.030 |
Why?
| | Lipoprotein Lipase | 1 | 2016 | 78 | 0.030 |
Why?
| | Remission Induction | 1 | 2016 | 258 | 0.030 |
Why?
| | Health Care Surveys | 1 | 1997 | 574 | 0.030 |
Why?
| | Pancreatitis | 1 | 2016 | 111 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 903 | 0.030 |
Why?
| | Health Education | 1 | 1997 | 337 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1642 | 0.030 |
Why?
| | Coroners and Medical Examiners | 1 | 1994 | 8 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2669 | 0.030 |
Why?
| | Death Certificates | 1 | 1994 | 27 | 0.030 |
Why?
| | Hospitals, Low-Volume | 1 | 2014 | 27 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2014 | 141 | 0.030 |
Why?
| | Societies, Medical | 1 | 1997 | 754 | 0.030 |
Why?
| | Risk Adjustment | 1 | 2014 | 85 | 0.030 |
Why?
| | Cross Infection | 1 | 2015 | 220 | 0.030 |
Why?
| | Program Evaluation | 1 | 1997 | 896 | 0.030 |
Why?
| | Biomarkers | 1 | 2023 | 3736 | 0.030 |
Why?
| | Public Health | 1 | 1997 | 493 | 0.030 |
Why?
| | Colorado | 1 | 2023 | 4471 | 0.030 |
Why?
| | Pancreatic Neoplasms | 1 | 2019 | 759 | 0.020 |
Why?
| | Utah | 1 | 2011 | 68 | 0.020 |
Why?
| | Sex Factors | 2 | 2014 | 1901 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 1997 | 845 | 0.020 |
Why?
| | Odds Ratio | 1 | 2014 | 1050 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 429 | 0.020 |
Why?
| | Population Surveillance | 1 | 1994 | 444 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1341 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 558 | 0.020 |
Why?
| | Goals | 1 | 2011 | 171 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2805 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2001 | 5061 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 1997 | 1248 | 0.020 |
Why?
| | Triage | 1 | 2011 | 221 | 0.020 |
Why?
| | Quality Indicators, Health Care | 1 | 2011 | 318 | 0.020 |
Why?
| | Pregnancy | 1 | 1997 | 5922 | 0.020 |
Why?
| | Iowa | 1 | 1994 | 26 | 0.010 |
Why?
| | Homicide | 1 | 1994 | 52 | 0.010 |
Why?
| | Bias | 1 | 1994 | 216 | 0.010 |
Why?
| | Accidental Falls | 1 | 1994 | 160 | 0.010 |
Why?
| | Suicide | 1 | 1994 | 526 | 0.000 |
Why?
|
|
Bennett's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|